The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Current status of functional dyspepsia in Korea

  • Lee, Hyuk (Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine) ;
  • Jung, Hye-Kyung (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Huh, Kyu Chan (Department of Internal Medicine, Konyang University College of Medicine) ;
  • Functional Dyspepsia Study Group in the Korean Society of Neurogastroenterology and Motility (Korean Society of Neurogastroenterology and Motility)
  • Received : 2014.01.07
  • Accepted : 2014.02.04
  • Published : 2014.03.01
⟨ Previous Next ⟩

Abstract

Dyspepsia refers to group of commonly occurring upper gastrointestinal symptoms. The majority of patients with dyspepsia suffer from functional (nonulcer) dyspepsia. Although there is a lack of epidemiological data from population-based or patient cohort studies in Korea, the current understanding of this condition has been updated using data from various recent research studies, which have facilitated the development of clinical guidelines for functional dyspepsia. According to a survey using the Rome III criteria, more than 40% of respondents who visited primary clinics and tertiary hospitals were defined as having functional dyspepsia, most of who were within a subgroup of patients with postprandial distress syndrome. In addition, a population-based cross-sectional survey revealed considerable overlap between functional dyspepsia and other functional gastrointestinal disorders, including gastroesophageal reflux disease (especially nonerosive reflux disease) and irritable bowel syndrome. In contrast to the results of Western trials, there is insufficient evidence to recommend a Helicobacter pylori test-and-treat strategy as an initial management approach to functional dyspepsia in Korea, suggesting the need for early endoscopic evaluation. Additional studies are necessary to adjust the cutoff age for implementation of immediate endoscopic evaluation of patients without alarm symptoms. Considering the prevalence of H. pylori infection and the limited efficacy of symptomatic relief after its eradication, further well-qualified studies in Korea are warranted.

Keywords

References

  1. Nyren O, Lindberg G, Lindstrom E, Marke LA, Seensalu R. Economic costs of functional dyspepsia. Pharmacoeconomics 1992;1:312-324. https://doi.org/10.2165/00019053-199201050-00003
  2. Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm 2004;10:299-309.
  3. Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Manag Care Pharm 2013;19:755-764.
  4. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 2008;20 Suppl 1:121-129. https://doi.org/10.1111/j.1365-2982.2008.01097.x
  5. Jung HK, Jang B, Kim YH, et al. Health care costs of digestive diseases in Korea. Korean J Gastroenterol 2011;58:323-331. https://doi.org/10.4166/kjg.2011.58.6.323
  6. Tack J, Talley NJ. Functional dyspepsia: symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol 2013;10:134-141. https://doi.org/10.1038/nrgastro.2013.14
  7. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479. https://doi.org/10.1053/j.gastro.2005.11.059
  8. Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013;10:168-174. https://doi.org/10.1038/nrgastro.2013.9
  9. Jee SR, Jung HK, Min BH, et al. Guidelines for the treatment of functional dyspepsia. Korean J Gastroenterol 2011;57:67-81. https://doi.org/10.4166/kjg.2011.57.2.67
  10. Jung HK, Keum BR, Jo YJ, et al. Diagnosis of functional dyspepsia: a systematic review. Korean J Gastroenterol 2010;55:296-307. https://doi.org/10.4166/kjg.2010.55.5.296
  11. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 2007;102:1983-1989. https://doi.org/10.1111/j.1572-0241.2007.01381.x
  12. Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009;137:94-100. https://doi.org/10.1053/j.gastro.2009.03.039
  13. Zagari RM, Law GR, Fuccio L, et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology 2010;138:1302-1311. https://doi.org/10.1053/j.gastro.2009.12.057
  14. Shin CM. Overlap between postprandial distress and epigastric pain syndromes in functional dyspepsia: its implications for research and clinical practice (Am J Gastroenterol 2013;108:767-774). J Neurogastroenterol Motil 2013;19:409-411. https://doi.org/10.5056/jnm.2013.19.3.409
  15. Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol 2006;12:2661-2666. https://doi.org/10.3748/wjg.v12.i17.2661
  16. Ghoshal UC, Singh R, Chang FY, et al. Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil 2011;17:235-244. https://doi.org/10.5056/jnm.2011.17.3.235
  17. Vakil N, Halling K, Ohlsson L, Wernersson B. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification. Am J Gastroenterol 2013;108:767-774. https://doi.org/10.1038/ajg.2013.89
  18. Choo KY, Choi MG, Choi H, et al. The prevalences of gastrointestinal symptoms in a rural community in Korea. Korean J Gastrointest Motil 2000;6:31-43.
  19. Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal ref lux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion 2009;79:196-201. https://doi.org/10.1159/000211715
  20. Rhie SY, Choi CH, Lee HW, et al. The frequency of functional dyspepsia subtypes and its related factors for health check up subjects. Korean J Neurogastroenterol Motil 2007;13:31-37.
  21. Kim JS, Lee KJ, Kim JH, Hahm KB, Cho SW. Functional gastrointestinal disorders in patients referred to specialist gastroenterologists in a tertiary hospital. Korean J Neurogastroenterol Motil 2004;10:111-117.
  22. Ji SW, Park HJ, Choi JP, Lee TH, Lee DY, Lee SI. Validation of Rome II criteria for functional gastrointestinal disorders in Korean patients. Korean J Gastroenterol 2003;41:183-189.
  23. Park JM, Choi MG, Cho YK, et al. Functional gastrointestinal disorders diagnosed by Rome III questionnaire in Korea. J Neurogastroenterol Motil 2011;17:279-286. https://doi.org/10.5056/jnm.2011.17.3.279
  24. Kim SE, Park HK, Kim N, et al. Prevalence and risk factors of functional dyspepsia: a nationwide multicenter prospective study in Korea. J Clin Gastroenterol 2014;48:e12-e18.
  25. Barry S, Dinan TG. Functional dyspepsia: are psychosocial factors of relevance? World J Gastroenterol 2006;12:2701-2707. https://doi.org/10.3748/wjg.v12.i17.2701
  26. Locke GR 3rd, Zinsmeister AR, Fett SL, Melton LJ 3rd, Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005;17:29-34. https://doi.org/10.1111/j.1365-2982.2004.00581.x
  27. Cremonini F, Talley NJ. Review article: the overlap between functional dyspepsia and irritable bowel syndrome: a tale of one or two disorders? Aliment Pharmacol Ther 2004;20 Suppl 7:40-49.
  28. Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil 2012;24:895-913. https://doi.org/10.1111/j.1365-2982.2012.01993.x
  29. Lee HJ, Lee SY, Kim JH, et al. Depressive mood and quality of life in functional gastrointestinal disorders: differences between functional dyspepsia, irritable bowel syndrome and overlap syndrome. Gen Hosp Psychiatry 2010;32:499-502. https://doi.org/10.1016/j.genhosppsych.2010.05.002
  30. Noh YW, Jung HK, Kim SE, Jung SA. Overlap of erosive and non-erosive ref lux diseases with functional gastrointestinal disorders according to Rome III criteria. J Neurogastroenterol Motil 2010;16:148-156. https://doi.org/10.5056/jnm.2010.16.2.148
  31. Camilleri CE, Carlson PJ, Camilleri M, et al. A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol 2006;101:581-592. https://doi.org/10.1111/j.1572-0241.2006.00481.x
  32. van Lelyveld N, Linde JT, Schipper M, Samsom M. Candidate genotypes associated with functional dyspepsia. Neurogastroenterol Motil 2008;20:767-773. https://doi.org/10.1111/j.1365-2982.2008.01102.x
  33. Park HY, Jahng JH, Lee YJ, Park H, Lee SI. Serotonin transporter gene and G-protein beta3 C825T gene polymorphism in patients with functional dyspepsia and irritable bowel syndrome. Korean J Neurogastroenterol Motil 2009;15:58-64.
  34. Kim HG, Lee KJ, Lim SG, Jung JY, Cho SW. G-protein beta3 subunit C825T polymorphism in patients with overlap syndrome of functional dyspepsia and irritable bowel syndrome. J Neurogastroenterol Motil 2012;18:205-210. https://doi.org/10.5056/jnm.2012.18.2.205
  35. Park CS, Uhm JH. Polymorphisms of the serotonin transporter gene and G-protein beta3 subunit gene in Korean children with irritable bowel syndrome and functional dyspepsia. Gut Liver 2012;6:223-228. https://doi.org/10.5009/gnl.2012.6.2.223
  36. Choung RS, Talley NJ, Crowell MD, et al. Validation of Rome III criteria for functional GI disorders. Gastroenterology 2007;132 Suppl 2:A676.
  37. Park H. Functional gastrointestinal disorders and overlap syndrome in Korea. J Gastroenterol Hepatol 2011;26 Suppl 3:12-14.
  38. Kim ES, Lee BJ, Kim YS, Lee SI, Park H. Validation of Rome III criteria in the diagnosis of functional gastrointestinal disorders in Korean patients. Korean J Neurogastroenterol Motil 2008;14:39-44.
  39. Song KH, Jung HK, Min BH, et al. Development and validation of the Korean Rome III questionnaire for diagnosis of functional gastrointestinal disorders. J Neurogastroenterol Motil 2013;19:509-515. https://doi.org/10.5056/jnm.2013.19.4.509
  40. Lee EH, Hahm KB, Lee JH, et al. Development and validation of a functional dyspepsia-related quality of life (FD-QOL) scale in South Korea. J Gastroenterol Hepatol 2006;21:268-274. https://doi.org/10.1111/j.1440-1746.2006.04196.x
  41. Song HJ, Jung HK. Reliability and validity of Korean bowel disease questionnaire for functional gastrointestinal disorders. Ewha Med J 2011;34:39-46. https://doi.org/10.12771/emj.2011.34.2.39
  42. Zagari RM, Law GR, Fuccio L, Pozzato P, Forman D, Bazzoli F. Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro study. Am J Gastroenterol 2010;105:565-571. https://doi.org/10.1038/ajg.2009.706
  43. Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA 2006;295:1566-1576. https://doi.org/10.1001/jama.295.13.1566
  44. Bowrey DJ, Griff in SM, Wayman J, Karat D, Hayes N, Raimes SA. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc 2006;20:1725-1728. https://doi.org/10.1007/s00464-005-0679-3
  45. Han CH, Lee JS, Ahn JO, et al. The meaning of warning symptoms in the patients with dyspepsia. Korean J Med 2007;73:25-33.
  46. Jung HK, Kim SE, Shim KN, Jung SA. Association between dyspepsia and upper endoscopic findings. Korean J Gastroenterol 2012;59:275-281. https://doi.org/10.4166/kjg.2012.59.4.275
  47. Kim JI, Jun EJ, Kim TH, et al. Endoscopic finding according to symptoms in patients with functional dyspepsia. Korean J Helicobacter Up Gastrointest Res 2011;11:124-128. https://doi.org/10.7704/kjhugr.2011.11.2.124
  48. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 2005;129:1756-1780. https://doi.org/10.1053/j.gastro.2005.09.020
  49. North of England Dyspepsia Guideline Development Group. Dyspepsia: Managing Dyspepsia in Adults in Primary Care. Newcastle upon Tyne: University of Newcastle upon Tyne, 2004.
  50. Veldhuyzen van Zanten SJ, Bradette M, Chiba N, et al. Evidence-based recommendations for short- and longterm management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol 2005;19:285-303. https://doi.org/10.1155/2005/674607
  51. Duggan AE, Elliott CA, Miller P, Hawkey CJ, Logan RF. Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care. Aliment Pharmacol Ther 2009;29:55-68. https://doi.org/10.1111/j.1365-2036.2008.03852.x
  52. Heaney A, Collins JS, Watson RG, McFarland RJ, Bamford KB, Tham TC. A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 1999;45:186-190. https://doi.org/10.1136/gut.45.2.186
  53. Ford AC, Qume M, Moayyedi P, et al. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology 2005;128:1838-1844. https://doi.org/10.1053/j.gastro.2005.03.004
  54. Schmidt N, Peitz U, Lippert H, Malfertheiner P. Missing gastric cancer in dyspepsia. Aliment Pharmacol Ther 2005;21:813-820. https://doi.org/10.1111/j.1365-2036.2005.02425.x
  55. Shin MH, Oh HK, Ahn YO. Ten year trend of cancer incidence in Seoul, Korea: 1993-2002. J Prev Med Public Health 2008;41:92-99. https://doi.org/10.3961/jpmph.2008.41.2.92
  56. Liou JM, Lin JT, Wang HP, et al. The optimal age threshold for screening upper endoscopy for uninvestigated dyspepsia in Taiwan, an area with a higher prevalence of gastric cancer in young adults. Gastrointest Endosc 2005;61:819-825. https://doi.org/10.1016/S0016-5107(05)00366-4
  57. Kim JH, Kim HY, Kim NY, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 2001;16:969-975. https://doi.org/10.1046/j.1440-1746.2001.02568.x
  58. Salkic NN, Zildzic M, Zerem E, et al. Simple uninvestigated dyspepsia: age threshold for early endoscopy in Bosnia and Herzegovina. Eur J Gastroenterol Hepatol 2009;21:39-44. https://doi.org/10.1097/MEG.0b013e328308b300
  59. Lee JH, Kim HY, Rho SH, et al. Dyspepsia in Korean population: who needs endoscopy? Korean J Gastrointest Endosc 2001;22:1-7.
  60. Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999;179:1523-1530. https://doi.org/10.1086/314785
  61. Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment- Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003;17:1481-1491. https://doi.org/10.1046/j.1365-2036.2003.01646.x
  62. McColl KE, el-Nujumi A, Murray L, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997;40:302-306. https://doi.org/10.1136/gut.40.3.302
  63. Asaka M, Kato M, Takahashi S, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010;15:1-20.
  64. Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587-1600. https://doi.org/10.1111/j.1440-1746.2009.05982.x
  65. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection: the Maastricht IV/ Florence Consensus Report. Gut 2012;61:646-664. https://doi.org/10.1136/gutjnl-2012-302084
  66. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-1825. https://doi.org/10.1111/j.1572-0241.2007.01393.x
  67. Suh SO, Lee DH, Park YS, et al. Difference in Helicobacter pylori eradication rates in patients with peptic ulcer and non-ulcer dyspepsia. Korean J Med 2006;70:505-510.
  68. Jung HK, Na YJ, Moon IH. Changes of Helicobacter pylori-positive peptic ulcer disease: based on data from a general hospital. Korean J Gastrointest Endosc 2006;32:1-8.
  69. Kim KC, Park HJ, Lee HW, et al. Relation of serum gastrin and pepsinogen levels to serologic recognition of CagA and VacA in Helicobacter pylori infection. Korean J Gastroenterol 1997;29:25-34.
  70. Park IS, Lee YC, Park HJ, et al. Helicobacter pylori infection in Korea. Yonsei Med J 2001;42:457-470. https://doi.org/10.3349/ymj.2001.42.4.457
  71. Hwang IR, Kim JH, Lee KJ, Cho SW. Can Helicobacter pylori serology predict non-ulcer dyspepsia in young dyspeptic patients? Korean J Gastrointest Endosc 2000;21:696-703.
  72. Kim SG, Jung HK, Lee HL, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Korean J Gastroenterol 2013;62:3-26. https://doi.org/10.4166/kjg.2013.62.1.3
  73. Harvey RF, Lane JA, Nair P, et al. Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations: the Bristol Helicobacter Project. Aliment Pharmacol Ther 2010;32:394-400. https://doi.org/10.1111/j.1365-2036.2010.04363.x
  74. McColl K, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1869-1874. https://doi.org/10.1056/NEJM199812243392601
  75. Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;(2):CD002096.
  76. Mazzoleni LE, Sander GB, Francesconi CF, et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med 2011;171:1929-1936. https://doi.org/10.1001/archinternmed.2011.533
  77. Gwee KA, Teng L, Wong RK, Ho KY, Sutedja DS, Yeoh KG. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2009;21:417-424. https://doi.org/10.1097/MEG.0b013e328317b89e
  78. Moayyedi P, Soo S, Deeks J, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 2000;321:659-664. https://doi.org/10.1136/bmj.321.7262.659
  79. Hong SJ, Sung IK, Kim JG, et al. Failure of a randomized, double-blind, placebo-controlled study to evaluate the eff icacy of H. pylori eradication in H. pylori-infected patients with functional dyspepsia. Gut Liver 2011;5:468-471. https://doi.org/10.5009/gnl.2011.5.4.468
  80. Kim SH, Hong DY, Kang PS, et al. Community-based Helicobacter pylori screening and its effects on eradication in patients with dyspepsia. Korean J Prev Med 2000;33:285-298.
  81. Lee EJ, Gham CW, Park TW, et al. The effect of Helicobacter pylori eradication on the improvement of the symptoms in patients with functional dyspepsia and peptic ulcer disease. Korean J Med 2006;71:141-148.
  82. Rhee PL, Kim YH, Son HJ, et al. Lack of association of Helicobacter pylori infection with gastric hypersensitivity or delayed gastric emptying in functional dyspepsia. Am J Gastroenterol 1999;94:3165-3169. https://doi.org/10.1111/j.1572-0241.1999.01511.x
  83. Shim SG, Rhee PL, Kim YH, et al. Influence of Helicobacter pylori infection on proximal gastric motor function in functional dyspepsia. Korean J Gastroenterol 1999;34:143-150.
  84. Lee SY, Lee YD, Jeon SW, et al. The effect of Helicobacter pylori infection on gastric emptying in patients with functional dyspepsia. Korean J Gastroenterol 2000;35:677-686.
  85. Kim SE, Park YS, Kim N, et al. Effect of Helicobacter pylori eradication on functional dyspepsia. J Neurogastroenterol Motil 2013;19:233-243. https://doi.org/10.5056/jnm.2013.19.2.233
  86. Yoon BC. Treatment of Helicobacter pylori infection in functional dyspepsia. Korean J Med 2008;75:492-495.

Cited by

  1. Correlation between social factors and anxiety-depression in function dyspepsia: do relationships exist? vol.9, pp.6, 2014, https://doi.org/10.5114/pg.2014.47897
  2. Current Issues in Functional Dyspepsia vol.64, pp.3, 2014, https://doi.org/10.4166/kjg.2014.64.3.133
  3. Medical treatment of functional dyspepsia vol.30, pp.1, 2015, https://doi.org/10.7180/kmj.2015.30.1.1
  4. Nodule Regression in Adults With Nodular Gastritis vol.8, pp.6, 2014, https://doi.org/10.14740/gr692w
  5. Functional dyspepsia: new insights into pathogenesis and therapy vol.31, pp.3, 2016, https://doi.org/10.3904/kjim.2016.091
  6. Effect of acupuncture and its influence on cerebral activity in functional dyspepsia patients: study protocol for a randomized controlled trial vol.17, pp.1, 2014, https://doi.org/10.1186/s13063-016-1296-2
  7. Comparative Researches of Semen Arecae and Charred Semen Arecae on Gastrointestinal Motility, Motilin, Substance P, and CCK in Chronically Stressed Rats vol.2017, pp.None, 2017, https://doi.org/10.1155/2017/1273561
  8. Effects of a Herbal Medicine, Yukgunja-Tang, on Functional Dyspepsia Patients Classified by 3-Dimensional Facial Measurement: A Study Protocol for Placebo-Controlled, Double-Blind, Randomized Trial vol.2017, pp.None, 2014, https://doi.org/10.1155/2017/2894507
  9. Certain Dietary Habits Contribute to the Functional Dyspepsia in South China Rural Area vol.23, pp.None, 2014, https://doi.org/10.12659/msm.902705
  10. Understanding the Biliary Dyspepsia vol.23, pp.4, 2014, https://doi.org/10.15279/kpba.2018.23.4.150
  11. Antibiotic Susceptibility Assessment of Helicobacter pylori Isolates by Disk-Diffusion Method vol.8, pp.3, 2014, https://doi.org/10.1007/s12668-018-0527-2
  12. Relationship between job stress and functional dyspepsia in display manufacturing sector workers: a cross-sectional study vol.30, pp.1, 2018, https://doi.org/10.1186/s40557-018-0274-4
  13. Functional Dyspepsia vol.73, pp.2, 2014, https://doi.org/10.4166/kjg.2019.73.2.77
  14. A Randomized Double-blind Comparative Study of the Efficacy of Helicobacter pylori Eradication Therapy and Motilitone® for Functional Dyspepsia vol.19, pp.2, 2014, https://doi.org/10.7704/kjhugr.2019.19.2.106
  15. A clinical study on safety and efficacy of Naesohwajung-tang on functional dyspepsia vol.99, pp.21, 2020, https://doi.org/10.1097/md.0000000000019910
  16. Correlation between sleep impairment and functional dyspepsia vol.48, pp.7, 2014, https://doi.org/10.1177/0300060520937164
  17. Correlation between lifestyle and social factors in functional dyspepsia among college freshmen vol.48, pp.8, 2014, https://doi.org/10.1177/0300060520939702
  18. The Effect of Proton Pump Inhibitor and Prokinetics Combination Therapy for Functional Dyspepsia vol.77, pp.4, 2021, https://doi.org/10.4166/kjg.2021.060